VIENNA, Va., May 15, 2025--(BUSINESS WIRE)--CEL-SCI Corporation (NYSE American: CVM) today reported financial results for the three months ended March 31, 2025, as well as key recent clinical and ...

In exchange for the doubling of the term of its contract, Casella has agreed to spend “approximately $1.2 million this year to purchase 18,000 new 96-gallon blue garbage totes.” According to a ...

Anthony Casella, 87, a former mayor and trustee of the Village of East Williston, died Monday night of natural causes. Casella is remembered by his family and colleagues as a dedicated public ...

VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation (“CEL-SCI” or the “Company”) (NYSE American: CVM), a clinical stage cancer immunotherapy company, today announced that it intends to offer ...

Products Market Alerts MyCollection Price Database Become a Partner Gallery ...

New AI Tool Reveals Single-Cell Structure of Chromosomes -- In 3D May 28, 2025 — In a major leap forward for genetic and biomedical research, scientists have developed a powerful new artificial ...

Chimeric antigen receptor (CAR) T cells targeting CD19 have transformed the treatment of B-cell cancers, but many patients do not have long-term remission. We designed an anti-CD19 enhanced ...

An often-ignored type of cell in the brain plays a dynamic and surprisingly complex role in our ability to process information, according to new research. An often-ignored type of cell in the ...

PHILADELPHIA, May 15, 2025 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell ...

More information: Mats Jerkeman et al, Implementation of standard of care CAR-T-cell treatment for patients with aggressive B-cell lymphoma and acute lymphoblastic leukemia in Sweden, Leukemia (2025).